The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,300.00
Bid: 2,300.00
Ask: 2,350.00
Change: 0.00 (0.00%)
Spread: 50.00 (2.174%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

8 Nov 2017 07:00

RNS Number : 8493V
Craneware plc
08 November 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

AGM Statement

 

8 November 2017 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 2pm. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

"We have experienced a positive start to trading in the first four months of the year, adding to the recent announcement of the $6m contract win extending the scope of our solutions within an existing customer. In June, we launched Trisus Claims Informatics, the first product on our cloud-based Trisus platform, to which we have seen a positive market response. In addition, we are seeing very encouraging results for the early adopters of our Trisus Cost Analytics Resource Efficiency product, which is currently under development within Craneware Healthcare Intelligence.

 

"The sales activity and the early product successes demonstrate how we are benefiting from our ongoing investments in our Value Cycle product suite, ensuring we have the solutions that provide insight into key areas of hospital operations, expanding our market opportunity and increasing our strategic value within our market.

 

"Our leadership in this area has further strengthened Craneware's position as a trusted partner for US healthcare organisations as they look to solve the challenges of the new value based reimbursement models.

 

"This positive impact of the Value Cycle on current sales and underlying pipelines combined with the high levels of revenue visibility and significant cash reserves, means we are well positioned to continue to execute on our growth strategy."

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

Hilary Buchanan

George Sellar

Robyn Fisher

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBCBDBGGGBGRR
Date   Source Headline
26th May 20237:22 amRNSTransaction in Own Shares
25th May 20237:00 amRNSTransaction in Own Shares
24th May 20237:00 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSTransaction in Own Shares
22nd May 20237:00 amRNSTransaction in Own Shares
19th May 20237:00 amRNSTransaction in Own Shares
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:02 amRNSTransaction in Own Shares
12th May 20239:21 amRNSTransaction in Own Shares
11th May 20237:00 amRNSTransaction in Own Shares
5th May 202312:35 pmRNSNotification of Major Holdings
28th Apr 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in own shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSBlock Listing Announcement
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:18 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSShare Buyback Programme
24th Mar 202311:02 amRNSDividend Currency Election
14th Mar 20237:00 amRNSDirector Share Purchase
6th Mar 20237:00 amRNSInterim Results
13th Feb 20235:15 pmRNSHolding(s) in Company
1st Feb 20233:25 pmRNSDirector Share Purchase
27th Jan 20237:31 amRNSDirector Share Purchase
19th Jan 20232:05 pmRNSSecond Price Monitoring Extn
19th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSTrading Update and Notice of Results
25th Nov 20222:14 pmRNSDividend Currency Election
25th Nov 20229:16 amRNSHolding(s) in Company
21st Nov 202211:40 amRNSGrant of Long Term Incentive Plan Awards
15th Nov 20222:25 pmRNSResult of AGM
15th Nov 20227:00 amRNSAGM Statement and Board Appointment
4th Nov 20221:33 pmRNSHolding(s) in Company
14th Oct 20225:22 pmRNSPosting of Annual Report and Notice of AGM
14th Oct 20227:00 amRNSBlock listing Interim Review
11th Oct 20224:19 pmRNSHolding(s) in Company
10th Oct 202211:10 amRNSHolding(s) in Company
10th Oct 202211:02 amRNSHolding(s) in Company
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.